Reymann A - Search Results

1

Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.

Harsch M, Gebhardt A, Reymann A, Lang G, Schliack M, Löser R, Braesen JH, Niendorf A. Harsch M, et al. Among authors: reymann a. Br J Pharmacol. 1998 May;124(2):277-82. doi: 10.1038/sj.bjp.0701831. Br J Pharmacol. 1998. PMID: 9641543 Free PMC article.

2

Sensitive assessment of cytostatic drug resistance-mediating factors MDR1 and MRP in tumors of the gastrointestinal tract by RT-PCR.

Reymann A, Woermann C, Fröschle G, Schneider C, Bräsen JH, Lage H, Dietel M. Reymann A, et al. Int J Clin Pharmacol Ther. 1998 Jan;36(1):55-7. Int J Clin Pharmacol Ther. 1998. PMID: 9476150 No abstract available.

3

Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells.

Schaefer A, Westendorf J, Lingelbach K, Schmidt CA, Mihalache DL, Reymann A, Marquardt H. Schaefer A, et al. Among authors: reymann a. Cancer Chemother Pharmacol. 1993;31(4):301-7. doi: 10.1007/BF00685675. Cancer Chemother Pharmacol. 1993. PMID: 8422694

4

Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl.

Reymann A, Looft G, Woermann C, Dietel M, Erttmann R. Reymann A, et al. Cancer Chemother Pharmacol. 1993;32(1):25-30. doi: 10.1007/BF00685872. Cancer Chemother Pharmacol. 1993. PMID: 8462120

5

[Morphological and functional features of cytostatic drug resistance and the effects of MDR modulators].

Reymann A, Bunge A, Läer S, Dietel M. Reymann A, et al. Pharmazie. 1996 Mar;51(3):171-6. Pharmazie. 1996. PMID: 8900868 German.

6

Evidence for adenosine A1 receptor action in rat jejunal mucosa.

Reymann A, Gniess A. Reymann A, et al. Eur J Pharmacol. 1988 Apr 27;149(1-2):155-8. doi: 10.1016/0014-2999(88)90055-6. Eur J Pharmacol. 1988. PMID: 2840297

7

Expression of the novel mitoxantrone resistance associated gene MXR7 in colorectal malignancies.

Lage H, Dietel M, Fröschle G, Reymann A. Lage H, et al. Among authors: reymann a. Int J Clin Pharmacol Ther. 1998 Jan;36(1):58-60. Int J Clin Pharmacol Ther. 1998. PMID: 9476151

8

No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.

Hegewisch-Becker S, Staib F, Löning T, Pichlmeier U, Kröger N, Reymann A, Hossfeld DK. Hegewisch-Becker S, et al. Among authors: reymann a. Ann Oncol. 1998 Jan;9(1):85-93. doi: 10.1023/a:1008255725515. Ann Oncol. 1998. PMID: 9541688 Free article.

9

The technique of endobronchial lidocaine administration does not influence plasma concentration profiles and pharmacokinetic parameters in humans.

Steinfath M, Scholz J, Schulte am Esch J, Läer S, Reymann A, Scholz H. Steinfath M, et al. Among authors: reymann a. Resuscitation. 1995 Feb;29(1):55-62. doi: 10.1016/0300-9572(94)00817-y. Resuscitation. 1995. PMID: 7784724 Clinical Trial.

10

Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.

Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A. Dietel M, et al. Among authors: reymann a. J Cancer Res Clin Oncol. 1994;120(5):263-71. doi: 10.1007/BF01236382. J Cancer Res Clin Oncol. 1994. PMID: 7907333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters